Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

NCT00323856 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hemophilia A

Interventions

DRUG: Alphanate SD/HT

Sponsor

Grifols Biologicals, LLC